comparemela.com

Page 2 - Zach Herschfus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oramed to Present at the 83rd American Diabetes Association Conference

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract.

United statesSan diegoSan diego convention centerZach herschfusOramed pharmaceuticals nasdaqPrnewswire oramed pharmaceuticals incCompany contactOramed pharmaceuticalsOramed pharmaceuticals incAmerican diabetes associationExchange commissionScientific sessionsOral insulin alleviates liver fibrosisReduces fatMetabolic liver diseaseFrom bench

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will.

United statesMiriam kidronZach herschfusOramed pharmaceuticalsPrnewswire oramed pharmaceuticals incOramed pharmaceuticals nasdaqCompany contactOramed pharmaceuticals incChief scientific officerNovel therapiesObesity summitHyatt regency bostonProtein oral deliveryOramed pharmaceuticals incHealth care amp hospitalsMedical pharmaceuticals

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China

Oramed has completed an analysis of its U.S.-based Phase 3 oral insulin trial with significant lowering of A1C levels seen in patient subgroups NEW YORK, May 15, 2023 /PRNewswire/ Oramed. | May 15, 2023

United statesZach herschfusNadav kidronOramed pharmaceuticals nasdaqOramed pharmaceuticalsPrnewswire oramed pharmaceuticals incCompany contactOramed pharmaceuticals incHefei tianhui biotechnology co ltdExchange commissionNational medical products administrationHefei tianhui biotechnologyOramed chief executive officerProtein oral deliveryMethodology usedAnnual report

Oramed Appoints Ben Shapiro to its Board of Directors

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) ("Oramed" or the "Company") (www.oramed.com) announced today the appointment of Mr. Benjamin.

New yorkUnited statesBen shapiroNadav kidronZach herschfusBenjamin shapiroOramed pharmaceuticals incNew york timesPrnewswire oramed pharmaceuticals incHarvard law schoolExchange commissionCompany contactOramed pharmaceuticalsOramed pharmaceuticals nasdaqNasdaq capitalDaily wire

Oramed Appoints Ben Shapiro to its Board of Directors

NEW YORK, May 1, 2023 /PRNewswire/ Oramed Pharmaceuticals Inc. announced today the appointment of Mr. Benjamin Shapiro to its Board of Directors effective May 1, 2023. The Board determined. | May 1, 2023

New yorkUnited statesBen shapiroNadav kidronZach herschfusBenjamin shapiroOramed pharmaceuticals nasdaqOramed pharmaceuticalsCompany contactExchange commissionHarvard law schoolPrnewswire oramed pharmaceuticals incNew york timesOramed pharmaceuticals incNasdaq capitalDaily wire

vimarsana © 2020. All Rights Reserved.